Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
RegulatoryAbbVie Launches Phase 2 Forehead Lines StudytodayMarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days agoBusiness & M&AAllergan Aesthetics Overhauls Loyalty ProgramtodayDevices & TechXERF Technology Enters Australian Market for Skin Tightening2 days agoBusiness & M&AEvolus Expands Estyme to Canada, Australia, New ZealandtodayMarketArm Fat Now Top Body Sculpting Concern in Singapore2 days agoDevices & TechSofwave Hits One Million Treatments MilestonetodayRegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days agoRegulatoryRevance Wins FDA Nod for Under-Eye InjectablesyesterdayMarketGLP-1 Pill Era Is Forcing Beauty Market ShiftyesterdayInjectablesAEON Releases Expanded ABP-450 Botox Biosimilar DatayesterdayDevices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday
Markets & Filings

Consent Decree

A court-approved settlement where a company agrees to conditions to resolve a government enforcement case.

Also known as: Consent Order, Settlement Agreement

What it is
A consent decree is a binding, court-approved agreement resolving a government enforcement action without admission of liability. The company agrees to remedies like divestitures, conduct limits, or compliance obligations. It ends the immediate legal fight.
What it does
A consent decree removes overhang uncertainty, often relieving a stock, but the required remedies can constrain future business. Investors weigh the relief against the operational cost of the terms. It can clear a merger to close with divestitures.
The evidence
Merger approvals conditioned on divestiture consent decrees have let deals close and lifted acquirers' shares on removed uncertainty.
Best for
Companies under enforcement or with pending merger reviews.
Pairs well with
antitrust-action, 8-k, event-driven
Use cautiously with
The remedies can be onerous; reading a settlement as pure good news ignores the ongoing compliance and divestiture drag.
Cautions
Terms may cap growth for years, so relief rallies can fade as constraints bite.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

More markets & filings

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo →